Skip to content
Try Mental Wellness – Lifestyle
Author:
Protego Biopharma
Protego Announces FDA IND Clearance for Phase 2/3 Study of PROT-001 in AL Amyloidosis
October 19, 2026
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
June 8, 2026